STOCK TITAN

[Form 4] Bausch Health Companies Inc Insider Trading Activity

Filing Impact
(High)
Filing Sentiment
(Very Positive)
Form Type
4
Rhea-AI Filing Summary

John Paulson, a director and the controlling person of Paulson Capital Inc., reported purchases of Bausch Health Companies common stock executed by funds he manages. The filings show three purchases: 2,000,000 shares at $6.35, 1,156,640 shares at $6.88, and 86,409 shares at $7.06, totaling 3,243,049 shares. After these transactions the reporting person’s indirect beneficial ownership is stated as 36,034,751 shares. The shares are held by managed funds and the report includes a disclaimer that the reporting person disclaims beneficial ownership except to the extent of any pecuniary interest. No derivative securities were reported on the form.

John Paulson, amministratore e persona di controllo di Paulson Capital Inc., ha segnalato acquisti di azioni ordinarie di Bausch Health Companies eseguiti da fondi che gestisce. Le comunicazioni mostrano tre acquisti: 2.000.000 di azioni a $6,35, 1.156.640 di azioni a $6,88 e 86.409 di azioni a $7,06, per un totale di 3.243.049 azioni. Dopo queste operazioni, la partecipazione beneficiaria indiretta del dichiarante è indicata in 36.034.751 azioni. Le azioni sono detenute dai fondi gestiti e il rapporto include una clausola in cui il dichiarante rinuncia alla titolarità beneficiaria, salvo nella misura di eventuali interessi patrimoniali. Sul modulo non sono stati segnalati strumenti derivati.

John Paulson, director y persona de control de Paulson Capital Inc., informó compras de acciones ordinarias de Bausch Health Companies realizadas por fondos que administra. Las presentaciones registran tres adquisiciones: 2.000.000 de acciones a $6,35, 1.156.640 de acciones a $6,88 y 86.409 de acciones a $7,06, sumando 3.243.049 acciones. Tras estas operaciones, la participación beneficiaria indirecta del informante se declara en 36.034.751 acciones. Las acciones están en manos de los fondos gestionados y el informe incluye una cláusula en la que el informante renuncia a la titularidad beneficiaria, salvo en la medida de cualquier interés pecuniario. No se informaron valores derivados en el formulario.

Paulson Capital Inc.의 이사이자 통제권자인 John Paulson은 그가 운용하는 펀드들이 실행한 Bausch Health Companies 보통주 매입을 신고했습니다. 제출서류에는 세 건의 매입이 명시되어 있습니다: 2,000,000주를 주당 $6.35에, 1,156,640주를 주당 $6.88에, 86,409주를 주당 $7.06에, 총 3,243,049주입니다. 이 거래들 이후 신고인의 간접적 실소유 지분은 36,034,751주로 기재되어 있습니다. 해당 주식은 운용 중인 펀드가 보유하고 있으며, 보고서에는 신고인이 금전적 이익의 범위를 제외하고는 실소유를 부인한다고 명시되어 있습니다. 서류상 파생상품 증권은 보고되지 않았습니다.

John Paulson, administrateur et personne exerçant le contrôle de Paulson Capital Inc., a déclaré des achats d'actions ordinaires de Bausch Health Companies effectués par des fonds qu'il gère. Les déclarations font état de trois achats : 2 000 000 d'actions à 6,35 $, 1 156 640 d'actions à 6,88 $ et 86 409 d'actions à 7,06 $, soit au total 3 243 049 actions. Après ces opérations, la participation bénéficiaire indirecte de la personne déclarante est indiquée à 36 034 751 actions. Les actions sont détenues par des fonds gérés et le rapport comporte une clause précisant que la personne déclarante décline la qualité de propriétaire bénéficiaire, sauf dans la mesure d'un intérêt pécuniaire. Aucun titre dérivé n'a été déclaré sur le formulaire.

John Paulson, Direktor und kontrollierende Person von Paulson Capital Inc., meldete Käufe von Stammaktien der Bausch Health Companies, die von von ihm verwalteten Fonds ausgeführt wurden. Die Unterlagen weisen drei Käufe aus: 2.000.000 Aktien zu $6,35, 1.156.640 Aktien zu $6,88 und 86.409 Aktien zu $7,06, insgesamt 3.243.049 Aktien. Nach diesen Transaktionen wird das indirekte wirtschaftliche Eigentum der meldenden Person mit 36.034.751 Aktien angegeben. Die Aktien werden von verwalteten Fonds gehalten, und der Bericht enthält einen Haftungsausschluss, wonach die meldende Person das wirtschaftliche Eigentum nur insoweit verneint, wie ein finanzielles Interesse besteht. Im Formular wurden keine Derivate gemeldet.

Positive
  • Managed funds acquired a total of 3,243,049 BHC shares across three purchases.
  • Purchases executed at prices between $6.35 and $7.06, indicating active accumulation over consecutive days.
  • Reported indirect holdings increased to 36,034,751 shares, providing clear post-transaction ownership figures.
Negative
  • Holdings are reported as indirect by managed funds, and the reporting person disclaims beneficial ownership except to the extent of any pecuniary interest.
  • No derivative securities were reported, so there is no disclosed options or other instruments to amplify exposure.

Insights

Director-managed funds added 3.24M BHC shares, raising indirect holdings to 36.03M — a substantial accumulation by Paulson-managed vehicles.

The transactions consist of three purchases executed on consecutive days, totaling 3,243,049 shares at prices between $6.35 and $7.06. These purchases were reported as indirect holdings by funds managed by John Paulson, increasing the reported indirect stake to 36,034,751 shares. The Form 4 shows purchases only (transaction code 'P') and no derivative activity. From a market perspective, concentrated purchases by a prominent investment manager are material signals; the filing documents compliance with Section 16 reporting and includes a standard disclaimer about beneficial ownership.

Substantial purchases were made via managed funds, but the reporting person disclaims beneficial ownership, limiting direct disclosure of personal economic exposure.

The filing identifies John Paulson as a director and the investment manager of the funds that directly own the shares. It explicitly states that ownership is indirect (I) and includes the customary disclaimer under Rule 16a-1(a)(4) that the reporting person disclaims beneficial ownership except for any pecuniary interest. The Form was filed by one reporting person and documents only non-derivative purchases. From a governance standpoint, the indirect nature of the holdings and the disclaimer are important for understanding how much of the position is attributable to managed vehicles versus personal ownership.

John Paulson, amministratore e persona di controllo di Paulson Capital Inc., ha segnalato acquisti di azioni ordinarie di Bausch Health Companies eseguiti da fondi che gestisce. Le comunicazioni mostrano tre acquisti: 2.000.000 di azioni a $6,35, 1.156.640 di azioni a $6,88 e 86.409 di azioni a $7,06, per un totale di 3.243.049 azioni. Dopo queste operazioni, la partecipazione beneficiaria indiretta del dichiarante è indicata in 36.034.751 azioni. Le azioni sono detenute dai fondi gestiti e il rapporto include una clausola in cui il dichiarante rinuncia alla titolarità beneficiaria, salvo nella misura di eventuali interessi patrimoniali. Sul modulo non sono stati segnalati strumenti derivati.

John Paulson, director y persona de control de Paulson Capital Inc., informó compras de acciones ordinarias de Bausch Health Companies realizadas por fondos que administra. Las presentaciones registran tres adquisiciones: 2.000.000 de acciones a $6,35, 1.156.640 de acciones a $6,88 y 86.409 de acciones a $7,06, sumando 3.243.049 acciones. Tras estas operaciones, la participación beneficiaria indirecta del informante se declara en 36.034.751 acciones. Las acciones están en manos de los fondos gestionados y el informe incluye una cláusula en la que el informante renuncia a la titularidad beneficiaria, salvo en la medida de cualquier interés pecuniario. No se informaron valores derivados en el formulario.

Paulson Capital Inc.의 이사이자 통제권자인 John Paulson은 그가 운용하는 펀드들이 실행한 Bausch Health Companies 보통주 매입을 신고했습니다. 제출서류에는 세 건의 매입이 명시되어 있습니다: 2,000,000주를 주당 $6.35에, 1,156,640주를 주당 $6.88에, 86,409주를 주당 $7.06에, 총 3,243,049주입니다. 이 거래들 이후 신고인의 간접적 실소유 지분은 36,034,751주로 기재되어 있습니다. 해당 주식은 운용 중인 펀드가 보유하고 있으며, 보고서에는 신고인이 금전적 이익의 범위를 제외하고는 실소유를 부인한다고 명시되어 있습니다. 서류상 파생상품 증권은 보고되지 않았습니다.

John Paulson, administrateur et personne exerçant le contrôle de Paulson Capital Inc., a déclaré des achats d'actions ordinaires de Bausch Health Companies effectués par des fonds qu'il gère. Les déclarations font état de trois achats : 2 000 000 d'actions à 6,35 $, 1 156 640 d'actions à 6,88 $ et 86 409 d'actions à 7,06 $, soit au total 3 243 049 actions. Après ces opérations, la participation bénéficiaire indirecte de la personne déclarante est indiquée à 36 034 751 actions. Les actions sont détenues par des fonds gérés et le rapport comporte une clause précisant que la personne déclarante décline la qualité de propriétaire bénéficiaire, sauf dans la mesure d'un intérêt pécuniaire. Aucun titre dérivé n'a été déclaré sur le formulaire.

John Paulson, Direktor und kontrollierende Person von Paulson Capital Inc., meldete Käufe von Stammaktien der Bausch Health Companies, die von von ihm verwalteten Fonds ausgeführt wurden. Die Unterlagen weisen drei Käufe aus: 2.000.000 Aktien zu $6,35, 1.156.640 Aktien zu $6,88 und 86.409 Aktien zu $7,06, insgesamt 3.243.049 Aktien. Nach diesen Transaktionen wird das indirekte wirtschaftliche Eigentum der meldenden Person mit 36.034.751 Aktien angegeben. Die Aktien werden von verwalteten Fonds gehalten, und der Bericht enthält einen Haftungsausschluss, wonach die meldende Person das wirtschaftliche Eigentum nur insoweit verneint, wie ein finanzielles Interesse besteht. Im Formular wurden keine Derivate gemeldet.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Paulson John

(Last) (First) (Middle)
180 LAKEVIEW AVENUE

(Street)
WEST PALM BEACH FL 33401

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Bausch Health Companies Inc. [ BHC ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
08/11/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock, no par value 08/11/2025 P 2,000,000 A $6.35 34,791,702 I(1) By Managed Funds(1)
Common Stock, no par value 08/12/2025 P 1,156,640 A $6.88 35,948,342 I(1) By Managed Funds(1)
Common Stock, no par value 08/13/2025 P 86,409 A $7.06 36,034,751 I(1) By Managed Funds(1)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. John Paulson, the controlling person of Paulson Capital Inc. ("Paulson"), serves on the board of directors of the Issuer. Paulson is the investment manager of investment funds (the "Funds"). John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Act"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person.
JOHN PAULSON By: /s/ John Paulson John Paulson 08/13/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many BHC shares did John Paulson's managed funds purchase?

3,243,049 shares (2,000,000 at $6.35; 1,156,640 at $6.88; 86,409 at $7.06).

What are John Paulson's total BHC holdings after these transactions?

36,034,751 shares reported as indirectly beneficially owned by managed funds.

Were these transactions purchases or sales on the Form 4 for BHC?

Purchases. Each transaction is reported with transaction code 'P' indicating acquisition.

Did the Form 4 report any derivative securities for BHC?

No. Table II for derivative securities contains no reported transactions.

Were the shares acquired directly by John Paulson or through funds?

Indirectly through managed funds; the report notes the shares are directly owned by the Funds and Paulson is the investment manager.

Was the Form 4 filed by multiple reporting persons?

No. The form indicates it was filed by one reporting person.
Bausch Health Companies Inc

NYSE:BHC

BHC Rankings

BHC Latest News

BHC Latest SEC Filings

BHC Stock Data

2.59B
323.70M
10.99%
69.07%
2.01%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
Canada
QUEBEC